|
Combined NSMC and NSCS test results for the TP53 somatic mutations spectra |
||||
| Class ID |
Sites |
Mutations |
Hotspots |
P(H1)/χ2 |
|
|
||||
| Class Ia |
||||
| Synonymous |
157 |
390 |
76 |
|
| Non-synonymous |
527 |
5710 |
385 |
0.990/33.4 |
| Nonsense |
78 |
529 |
59 |
0.023 |
| Class IIb |
||||
| Synonymous |
172 |
391 |
97 |
|
| Non-synonymous |
495 |
6109 |
379 |
0.991/25.4 |
| Nonsense |
72 |
629 |
55 |
0.018 |
| Class IIIc |
||||
| Synonymous |
217 |
781 |
151 |
|
| Non-synonymous |
617 |
11819 |
474 |
0.994/4.47 |
| Nonsense |
88 |
1158 |
76 |
0.011 |
|
a Class I: combined mutational spectrum of the tumor types for which H0 is rejected in comparison of synonymous vs. non-synonymous substitutions:brain, liver, lung, colon, mouth, larynx, ovary and skin. b Class II: combined mutational spectrum of the tumor types for which the test did not find enough evidence, probably, because of the small sample size: bladder, breast, prostate, esophagus, colorectal, hematopoietic, stomach, and pancreas. c Class III: combined Class I and Class II spectra. Other designations are as in Table 1. | ||||
Glazko et al. Biology Direct 2006 1:4 doi:10.1186/1745-6150-1-4 |
||||